Skip to main navigation menu Skip to main content Skip to site footer


Vol. 151 No. 1920 (2021)

Supplementation of the population during the COVID-19 pandemic with vitamins and micronutrients – how much evidence is needed?

Cite this as:
Swiss Med Wkly. 2021;151:w20522


  1. World Health Organization. Coronavirus disease 2019 (COVID-19) Situation Report - 97. 2020.
  2. Gregoriano C Koch D Haubitz S Conen A Fux CA Mueller B Characteristics, predictors and outcomes among 99 patients hospitalised with COVID-19 in a tertiary care centre in Switzerland: an observational analysis. Swiss Med Wkly. 2020;150:w20316.
  3. Carr AC Maggini S. Vitamin C and Immune Function. Nutrients. 2017;9(11):1211. doi:.
  4. Hemilä H. Vitamin C and Infections. Nutrients. 2017;9(4):339. doi:.
  5. Gunville CF Mourani PM Ginde AA. The role of vitamin D in prevention and treatment of infection. Inflamm Allergy Drug Targets. 2013;12(4):239–45. doi:.
  6. Berger MM Herter-Aeberli I Zimmermann MB Spieldenner J Eggersdorfer M. Strengthening the immunity of the Swiss population with micronutrients: a narrative review and call for action. Clin Nutr ESPEN. 2021; (in production). doi:.
  7. Berger MM Pantet O Schneider A Ben-Hamouda N. Micronutrient Deficiencies in Medical and Surgical Inpatients. J Clin Med. 2019;8(7):931. doi:.
  8. Merker M Amsler A Pereira R Bolliger R Tribolet P Braun N Vitamin D deficiency is highly prevalent in malnourished inpatients and associated with higher mortality: A prospective cohort study. Medicine (Baltimore). 2019;98(48):e18113. doi:.
  9. Arvinte C Singh M Marik PE. Serum Levels of Vitamin C and Vitamin D in a Cohort of Critically Ill COVID-19 Patients of a North American Community Hospital Intensive Care Unit in May 2020: A Pilot Study. Med Drug Discov. 2020;8:100064. doi:.
  10. Ling SF Broad E Murphy R Pappachan JM Pardesi-Newton S Kong MF High-Dose Cholecalciferol Booster Therapy is Associated with a Reduced Risk of Mortality in Patients with COVID-19: A Cross-Sectional Multi-Centre Observational Study. Nutrients. 2020;12(12):3799. doi:.
  11. Mendy A Apewokin S Wells AA Morrow AL. Factors Associated with Hospitalization and Disease Severity in a Racially and Ethnically Diverse Population of COVID-19 Patients. medRxiv. 2020;2020.06.25.20137323.
  12. Merzon E Tworowski D Gorohovski A Vinker S Golan Cohen A Green I Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study. FEBS J. 2020;287(17):3693–702. doi:.
  13. Raisi-Estabragh Z McCracken C Bethell MS Cooper J Cooper C Caulfield MJ Greater risk of severe COVID-19 in Black, Asian and Minority Ethnic populations is not explained by cardiometabolic, socioeconomic or behavioural factors, or by 25(OH)-vitamin D status: study of 1326 cases from the UK Biobank. J Public Health (Oxf). 2020;42(3):451–60. doi:.
  14. Chiscano-Camón L Ruiz-Rodriguez JC Ruiz-Sanmartin A Roca O Ferrer R. Vitamin C levels in patients with SARS-CoV-2-associated acute respiratory distress syndrome. Crit Care. 2020;24(1):522. doi:.
  15. Hastie CE Mackay DF Ho F Celis-Morales CA Katikireddi SV Niedzwiedz CL Vitamin D concentrations and COVID-19 infection in UK Biobank. Diabetes Metab Syndr. 2020;14(4):561–5. doi:.
  16. Carpagnano GE Di Lecce V Quaranta VN Zito A Buonamico E Capozza E Vitamin D deficiency as a predictor of poor prognosis in patients with acute respiratory failure due to COVID-19. J Endocrinol Invest. 2021;44(4):765–71. doi:.
  17. Fasano A Cereda E Barichella M Cassani E Ferri V Zecchinelli AL COVID-19 in Parkinson’s Disease Patients Living in Lombardy, Italy. Mov Disord. 2020;35(7):1089–93. doi:.
  18. Tan CW Ho LP Kalimuddin S Cherng BPZ Teh YE Thien SY Cohort study to evaluate the effect of vitamin D, magnesium, and vitamin B12 in combination on progression to severe outcomes in older patients with coronavirus (COVID-19). Nutrition. 2020;79-80:111017. doi:.
  19. JamaliMoghadamSiahkali S Zarezade B Koolaji S SeyedAlinaghi S Zendehdel A Tabarestani M Safety and effectiveness of high-dose vitamin C in patients with COVID-19: a randomized open-label clinical trial. Eur J Med Res. 2021;26(1):20. doi:.
  20. Jing Zhang XR, Li Y, Zhu Y, Liu F, Guo G, Luo G, et al. High-dose vitamin C infusion for the treatment of critically ill COVID-19. Research Square. 2020. (Preprint).
  21. Thomas S Patel D Bittel B Wolski K Wang Q Kumar A Effect of High-Dose Zinc and Ascorbic Acid Supplementation vs Usual Care on Symptom Length and Reduction Among Ambulatory Patients With SARS-CoV-2 Infection: The COVID A to Z Randomized Clinical Trial. JAMA Netw Open. 2021;4(2):e210369. doi:.
  22. Entrenas Castillo M Entrenas Costa LM Vaquero Barrios JM Alcalá Díaz JF López Miranda J Bouillon R “Effect of calcifediol treatment and best available therapy versus best available therapy on intensive care unit admission and mortality among patients hospitalized for COVID-19: A pilot randomized clinical study”. J Steroid Biochem Mol Biol. 2020;203:105751. doi:.
  23. Murai IH Fernandes AL Sales LP Pinto AJ Goessler KF Duran CSC Effect of a Single High Dose of Vitamin D3 on Hospital Length of Stay in Patients With Moderate to Severe COVID-19: A Randomized Clinical Trial. JAMA. 2021;325(11):1053–60. doi:.
  24. Douglas RM Chalker EB Treacy B. Vitamin C for preventing and treating the common cold. Cochrane Database Syst Rev. 2000;(2):CD000980.
  25. Jolliffe DA Camargo CA Jr Sluyter JD Aglipay M Aloia JF Ganmaa D Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials. Lancet Diabetes Endocrinol. 2021;9(5):276–92. doi:.
  26. Schuetz P Fehr R Baechli V Geiser M Deiss M Gomes F Individualised nutritional support in medical inpatients at nutritional risk: a randomised clinical trial. Lancet. 2019;393(10188):2312–21. doi:.
  27. Martineau AR Forouhi NG. Vitamin D for COVID-19: a case to answer? Lancet Diabetes Endocrinol. 2020;8(9):735–6. doi:.

Most read articles by the same author(s)

1 2 3 > >>